After launching the NightBalance Lunoa sleep position
therapy device for patients with obstructive
sleep apnea in select markets in 2018, Philips has now
launched the product commercially. The product is
a mask-free, clinically-validated positional therapy
that uses gentle vibrations to encourage users to
alter their sleeping positions to help prevent apneas.
Philips has updated the technology to include wireless connectivity and a mobile
app that monitors use and provides patients and doctors with access to data via
a cloud-based system. The company cites several clinical studies that included
patient feedback on NightBalance, including their views that the product was
easier to use and more comfortable than other PAP therapy methods.
Contact the Editor.